Education
About Us
Working with TipRanks
Follow Us
CARsgen Therapeutics Holdings Ltd. (HK:2171)
:2171
2171 Stock Chart & Stats
HK$15.80
HK$0.27(2.96%)
At close: 4:00 PM EST
HK$15.80
HK$0.27(2.96%)
Day’s Range― - ―
52-Week RangeHK$6.97 - HK$25.60
Previous CloseN/A
Volume4.65M
Average Volume (3M)1.98M
Market Cap
HK$9.65B
Enterprise ValueHK$11.45B
Total Cash (Recent Filing)HK$1.26B
Total Debt (Recent Filing)HK$140.85M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
Mar 24, 2026EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding577,934,300
10 Day Avg. Volume1,760,508
30 Day Avg. Volume1,977,652
Financial Highlights & Ratios
PEG Ratio-0.80
Price to Book (P/B)4.53
Price to Sales (P/S)121.30
P/FCF Ratio-11.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CARsgen Therapeutics Holdings Ltd. News
2171 FAQ
What was CARsgen Therapeutics Holdings Ltd.’s price range in the past 12 months?
CARsgen Therapeutics Holdings Ltd. lowest stock price was HK$6.97 and its highest was HK$25.60 in the past 12 months.
What is CARsgen Therapeutics Holdings Ltd.’s market cap?
CARsgen Therapeutics Holdings Ltd.’s market cap is HK$9.65B.
When is CARsgen Therapeutics Holdings Ltd.’s upcoming earnings report date?
CARsgen Therapeutics Holdings Ltd.’s upcoming earnings report date is Mar 24, 2026 which is in 100 days.
How were CARsgen Therapeutics Holdings Ltd.’s earnings last quarter?
CARsgen Therapeutics Holdings Ltd. released its earnings results on Aug 15, 2025. The company reported -HK$0.153 earnings per share for the quarter, beating the consensus estimate of -HK$0.437 by HK$0.284.
Is CARsgen Therapeutics Holdings Ltd. overvalued?
According to Wall Street analysts CARsgen Therapeutics Holdings Ltd.’s price is currently Overvalued.
Does CARsgen Therapeutics Holdings Ltd. pay dividends?
CARsgen Therapeutics Holdings Ltd. does not currently pay dividends.
What is CARsgen Therapeutics Holdings Ltd.’s EPS estimate?
CARsgen Therapeutics Holdings Ltd.’s EPS estimate is -0.15.
How many shares outstanding does CARsgen Therapeutics Holdings Ltd. have?
CARsgen Therapeutics Holdings Ltd. has 577,934,300 shares outstanding.
What happened to CARsgen Therapeutics Holdings Ltd.’s price movement after its last earnings report?
CARsgen Therapeutics Holdings Ltd. reported an EPS of -HK$0.153 in its last earnings report, beating expectations of -HK$0.437. Following the earnings report the stock price went up 7.177%.
Which hedge fund is a major shareholder of CARsgen Therapeutics Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:2171
CARsgen Therapeutics Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
330.42%
12-Months-Change
Fundamentals
Return on Equity
-42.46%
Trailing 12-Months
Asset Growth
-26.61%
Trailing 12-Months
Company Description
CARsgen Therapeutics Holdings Ltd.
CARsgen Therapeutics Holdings Ltd. is a biotechnology company specializing in the research, development, and commercialization of innovative cell therapies. With a focus on oncology, the company leverages its proprietary technologies to develop a diverse pipeline of chimeric antigen receptor (CAR) T-cell therapies aimed at treating a variety of cancers. CARsgen is committed to advancing its therapies through rigorous clinical trials to provide safe and effective treatment options for cancer patients worldwide.
Technical Analysis
Ascletis Pharma, Inc.
―
Everest Medicines Ltd.
―
Lepu Biopharma Co. Ltd. Class H
―
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
―
Shanghai Haohai Biological Technology Co., Ltd. Class H
―
Options Prices
Currently, No data available
---